FTY720 Inhibits the Development of Collagen-Induced Arthritis in Mice by Suppressing the Recruitment of CD4⁺ T Lymphocytes

References

• LiJ, GangD, YuX, et al. Genistein: the potential for efficacy in rheumatoid arthritis. Clin Rheumatol. 2013;32(5):535–540. doi:10.1007/s10067-012-2148-423307323
   PubMed Web of Science ®Google Scholar
• TatangeloM, TomlinsonG, PatersonJM, et al. Association of patient, prescriber, and region with the initiation of first prescription of biologic disease-modifying antirheumatic drug among older patients with rheumatoid arthritis and identical health insurance coverage. JAMA Netw Open. 2019;2(12):e1917053. doi:10.1001/jamanetworkopen.2019.1705331808927
   PubMed Web of Science ®Google Scholar
• LiJ, LiJ, YueY, et al. Genistein suppresses tumor necrosis factor alpha-induced inflammation via modulating reactive oxygen species/Akt/nuclear factor kappaB and adenosine monophosphate-activated protein kinase signal pathways in human synoviocyte MH7A cells. Drug Des Devel Ther. 2014;8:315–323. doi:10.2147/DDDT.S52354
   Web of Science ®Google Scholar
• SpiegelS, MilstienS. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4(5):397–407. doi:10.1038/nrm110312728273
   PubMed Web of Science ®Google Scholar
• AdachiK, ChibaK. FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology. Perspect Medicin Chem. 2007;1:11–23. doi:10.1177/1177391X070010000219812733
   PubMedGoogle Scholar
• TsunemiS, IwasakiT, KitanoS, ImadoT, MiyazawaK, SanoH. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model. Clin immunol. 2010;136(2):197–204. doi:10.1016/j.clim.2010.03.42820421177
   PubMed Web of Science ®Google Scholar
• LiuYR, YangL, XuQQ, et al. Long noncoding RNA MEG3 regulates rheumatoid arthritis by targeting NLRC5. J Cell Physiol. 2019;234(8):14270–14284. doi:10.1002/jcp.2812630644097
   PubMed Web of Science ®Google Scholar
• MosqueraN, Rodriguez-TrilloA, BlancoFJ, Mera-VarelaA, GonzalezA, CondeC. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes. J Pharmacol Exp Ther. 2020;372(2):185–192. doi:10.1124/jpet.119.26137031801802
   PubMed Web of Science ®Google Scholar
• BrandDD, LathamKA, RosloniecEF. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269–1275. doi:10.1038/nprot.2007.17317546023
   PubMed Web of Science ®Google Scholar
• ShiD, TianT, YaoS, et al. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus. Brain Behav Immun. 2018;70:293–304. doi:10.1016/j.bbi.2018.03.00929548997
   PubMed Web of Science ®Google Scholar
• YaoS, LiL, SunX, et al. FTY720 inhibits mpp+-induced microglial activation by affecting NLRP3 inflammasome activation. J Neuroimmune Pharmacol. 2019;14(3):478–492. doi:10.1007/s11481-019-09843-431069623
   PubMed Web of Science ®Google Scholar
• HanY, LiX, ZhouQ, et al. FTY720 abrogates collagen-induced arthritis by hindering dendritic cell migration to local lymph nodes. J Immunol. 2015;195(9):4126–4135. doi:10.4049/jimmunol.140184226416269
   PubMed Web of Science ®Google Scholar
• LeeWY, SanzMJ, WongCH, et al. Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia. Proc Natl Acad Sci U S A. 2014;111(38):13936–13941. doi:10.1073/pnas.140476911125205813
   PubMed Web of Science ®Google Scholar
• PitsonSM. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci. 2011;36(2):97–107. doi:10.1016/j.tibs.2010.08.00120870412
   PubMed Web of Science ®Google Scholar
• SalasA, PonnusamyS, SenkalCE, et al. Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood. 2011;117(22):5941–5952. doi:10.1182/blood-2010-08-30077221527515
   PubMed Web of Science ®Google Scholar
• AnelliV, GaultCR, SniderAJ, ObeidLM. Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. FASEB J. 2010;24(8):2727–2738. doi:10.1096/fj.09-15054020335228
   PubMed Web of Science ®Google Scholar
• PiX, TanSY, HayesM, et al. Sphingosine kinase 1-mediated inhibition of Fas death signaling in rheumatoid arthritis B lymphoblastoid cells. Arthritis Rheum. 2006;54(3):754–764. doi:10.1002/art.2163516508940
   PubMed Web of Science ®Google Scholar
• LaiWQ, IrwanAW, GohHH, et al. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol. 2008;181(11):8010–8017. doi:10.4049/jimmunol.181.11.801019017993
   PubMed Web of Science ®Google Scholar
• KitanoM, HlaT, SekiguchiM, et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 2006;54(3):742–753. doi:10.1002/art.2166816508938
   PubMed Web of Science ®Google Scholar
• ZhaoC, FernandesMJ, TurgeonM, et al. Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha. J Lipid Res. 2008;49(11):2323–2337. doi:10.1194/jlr.M800143-JLR20018658144
   PubMed Web of Science ®Google Scholar
• TakeshitaH, KitanoM, IwasakiT, et al. Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-kappaB ligand (RANKL) expression in rheumatoid arthritis. Biochem Biophys Res Commun. 2012;419(2):154–159. doi:10.1016/j.bbrc.2012.01.10322326262
   PubMed Web of Science ®Google Scholar
• DingesJ, HarrisCM, WallaceGA, et al. Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors. Bioorg Med Chem Lett. 2016;26(9):2297–2302. doi:10.1016/j.bmcl.2016.03.04327020302
   PubMed Web of Science ®Google Scholar
• MandalaS, HajduR, BergstromJ, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002;296(5566):346–349. doi:10.1126/science.107023811923495
   PubMed Web of Science ®Google Scholar
• MullerWA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 2003;24(6):327–334. doi:10.1016/S1471-4906(03)00117-012810109
   PubMed Web of Science ®Google Scholar
• EkenA, DuhenR, SinghAK, et al. S1P1 deletion differentially affects TH17 and Regulatory T cells. Sci Rep. 2017;7(1):12905. doi:10.1038/s41598-017-13376-229018225
   PubMed Web of Science ®Google Scholar
• ThomasK, SehrT, ProschmannU, et al. Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation. J Neuroinflammation. 2017;14(1):41. doi:10.1186/s12974-017-0817-628231856
   PubMed Web of Science ®Google Scholar
• SumitomoS, NagafuchiY, TsuchidaY, et al. Transcriptome analysis of peripheral blood from patients with rheumatoid arthritis: a systematic review. Inflamm Regen. 2018;38:21. doi:10.1186/s41232-018-0078-530410636
   PubMed Web of Science ®Google Scholar
• FonsekaCY, RaoDA, TeslovichNC, et al. Mixed-effects association of single cells identifies an expanded effector CD4 + T cell subset in rheumatoid arthritis. Sci Transl Med. 2018;10(463):eaaq0305. doi:10.1126/scitranslmed.aaq030530333237
   PubMed Web of Science ®Google Scholar
• WeigertA, OleschC, BruneB. Sphingosine-1-phosphate and macrophage biology-how the sphinx tames the big eater. Front Immunol. 2019;10:1706. doi:10.3389/fimmu.2019.0170631379883
   PubMed Web of Science ®Google Scholar
• BurgN, SwendemanS, WorgallS, HlaT, SalmonJE. Sphingosine 1-phosphate receptor 1 signaling maintains endothelial cell barrier function and protects against immune complex-induced vascular injury. Arthritis Rheumatol. 2018;70(11):1879–1889. doi:10.1002/art.4055829781582
   PubMed Web of Science ®Google Scholar
• SuZ, SunH, AoM, ZhaoC. Atomic force microscopy study of the anti-inflammatory effects of triptolide on rheumatoid arthritis fibroblast-like synoviocytes. Microsc Microanal. 2017;23(5):1002–1012. doi:10.1017/S143192761701239928743324
   PubMed Web of Science ®Google Scholar
• LeeCJ, MoonSJ, JeongJH, et al. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis. Cell Death Dis. 2018;9(3):401. doi:10.1038/s41419-018-0433-029540697
   PubMed Web of Science ®Google Scholar
• McWilliamsDF, FergusonE, YoungA, KielyPD, WalshDA. Discordant inflammation and pain in early and established rheumatoid arthritis: Latent Class Analysis of Early Rheumatoid Arthritis Network and British Society for Rheumatology Biologics Register data. Arthritis Res Ther. 2016;18(1):295.27964757
   PubMed Web of Science ®Google Scholar
• ChristianF, SmithEL, CarmodyRJ. The regulation of NF-kappaB subunits by phosphorylation. Cells. 2016;5(1). doi:10.3390/cells5010012
   Web of Science ®Google Scholar
• Bogunia-KubikK, WysoczanskaB, PiatekD, IwaszkoM, CiechomskaM, SwierkotJ. Significance of polymorphism and expression of miR-146a and NFkB1 genetic variants in patients with rheumatoid arthritis. Arch Immunol Ther Exp (Warsz). 2016;64(Suppl 1):131–136. doi:10.1007/s00005-016-0443-528083614
   PubMed Web of Science ®Google Scholar
• WangL, SongG, ZhengY, et al. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis. Arthritis Res Ther. 2015;17:227. doi:10.1186/s13075-015-0734-y26303122
   PubMed Web of Science ®Google Scholar
• WangL, MaH, XueY, ShiH, MaT, CuiX. Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-alpha serine/threonine-protein kinase and nuclear factor-kappaB signaling pathways. Exp Ther Med. 2018;15(2):1225–1232. doi:10.3892/etm.2017.557529403554
   PubMed Web of Science ®Google Scholar
• LiuG, YangK, BurnsS, ShresthaS, ChiH. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat Immunol. 2010;11(11):1047–1056. doi:10.1038/ni.193920852647
   PubMed Web of Science ®Google Scholar
• VenkatesanB, ValenteAJ, PrabhuSD, ShanmugamP, DelafontaineP, ChandrasekarB. EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling. J Mol Cell Cardiol. 2010;49(4):655–663. doi:10.1016/j.yjmcc.2010.05.00720538003
   PubMed Web of Science ®Google Scholar
• MorelJ, AudoR, HahneM, CombeB. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem. 2005;280(16):15709–15718. doi:10.1074/jbc.M41446920015684417
   PubMed Web of Science ®Google Scholar
• ZhaoY, ShiD, CaoK, et al. Fingolimod targets cerebral endothelial activation to block leukocyte recruitment in the central nervous system. J Leukoc Biol. 2018;103(1):107–118. doi:10.1002/JLB.3A0717-287R29345065
   PubMed Web of Science ®Google Scholar